US Patent 7973052 Compounds for the treatment of metabolic disorders
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+233 characters)
Article
Patent abstract
Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Kirvin L. Hodge0
Reid W. von Borstel0
Shalini Sharma0
Stephen D. Wolpe0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07973052 Compounds for the treatment of metabolic disorders US Patent 7973052 Compounds for the treatment of metabolic disorders
Infobox
Patent Number
079730520
Patent Number
79730520
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079730520
Date of Patent
July 5, 2011
0Patent Application Number
123926750
Date Filed
February 25, 2009
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07973052 Compounds for the treatment of metabolic disorders
Infobox
Is a
Patent jurisdiction
Patent number
07973052
Date of patent
July 5, 2011
Patent application number
12392675
Date Filed
February 25, 2009
Patent primary examiner
Find more entities like US Patent 7973052 Compounds for the treatment of metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
